[XENE] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
08-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -19.23%
YoY- -140.53%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 9 132 536 8,766 3,737 -
PBT -47,681 -41,437 -36,256 -37,737 -31,198 -20,064 -25,080 53.64%
Tax -220 290 1,139 -587 -40 -394 484 -
NP -47,461 -41,727 -37,395 -37,150 -31,158 -19,670 -25,564 51.22%
Tax Rate - - - - - - - -
Total Cost 47,461 41,727 37,404 37,282 31,694 28,436 29,301 38.04%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 -426,591.38 -28,143.94 -5,813.06 -224.39 -684.08 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.72 -0.63 -0.57 -0.59 -0.55 -0.37 -0.62 10.51%
EPS Diluted -0.72 -0.63 -0.57 -0.57 -0.55 -0.36 -0.62 10.51%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.